[go: up one dir, main page]

ES2196148T3 - (hipersvirus) recombinado y utilizacion de un promotor de gen gb. - Google Patents

(hipersvirus) recombinado y utilizacion de un promotor de gen gb.

Info

Publication number
ES2196148T3
ES2196148T3 ES96914457T ES96914457T ES2196148T3 ES 2196148 T3 ES2196148 T3 ES 2196148T3 ES 96914457 T ES96914457 T ES 96914457T ES 96914457 T ES96914457 T ES 96914457T ES 2196148 T3 ES2196148 T3 ES 2196148T3
Authority
ES
Spain
Prior art keywords
gene
promoter
alien
hipersvirus
gen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96914457T
Other languages
English (en)
Inventor
Kengo Sonoda
Masashi Sakaguchi
Kazuo Matsuo
Fukusaburo Hamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of ES2196148T3 publication Critical patent/ES2196148T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN HERPESVIRUS RECOMBINANTE CAPAZ DE EXPRESAR DE FORMA EFICAZ LA PROTEINA EXTRAÑA DIANA EN UN ANIMAL HUESPED QUE HA SIDO INOCULADO CON LA MISMA Y QUE EJERCE UN EXCELENTE EFECTO INMUNOLOGICO. EL HERPESVIRUS RECOMBINANTE TIENE UN ENVASE DE EXPRESION DE GEN EXTRAÑO INTEGRADO EN EL MISMO EN DONDE UN GEN GB QUE ORIGINA UN PROMOTOR DE HERPESVIRUS (UN GEN HOMOLOGO CON EL GEN HERPES SIMPLEX VIRUS GB) SE EMPLEA COMO UN PROMOTOR PARA LA EXPRESION DEL GEN EXTRAÑO.
ES96914457T 1995-06-02 1996-05-28 (hipersvirus) recombinado y utilizacion de un promotor de gen gb. Expired - Lifetime ES2196148T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7160106A JPH08322559A (ja) 1995-06-02 1995-06-02 ｇＢ遺伝子プロモーターを用いた組換えヘルペスウイルス

Publications (1)

Publication Number Publication Date
ES2196148T3 true ES2196148T3 (es) 2003-12-16

Family

ID=15707989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96914457T Expired - Lifetime ES2196148T3 (es) 1995-06-02 1996-05-28 (hipersvirus) recombinado y utilizacion de un promotor de gen gb.

Country Status (11)

Country Link
US (1) US6013261A (es)
EP (1) EP0774513B1 (es)
JP (2) JPH08322559A (es)
CN (1) CN1155710C (es)
AT (1) ATE236254T1 (es)
AU (1) AU692395B2 (es)
BR (1) BR9606412A (es)
CA (1) CA2196416C (es)
DE (1) DE69627109T2 (es)
ES (1) ES2196148T3 (es)
WO (1) WO1996038565A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
HUP9802974A1 (hu) * 1998-12-19 2000-09-28 Mezőgazdasági Biotechnológiai Kutatóközpont Fertőző bursitis elleni DNS-vakcina
US6764684B2 (en) 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
CN100510082C (zh) * 2007-06-18 2009-07-08 扬州大学 一种淋巴组织特异性基因表达调控序列
CN103235127A (zh) * 2013-04-17 2013-08-07 河南省农业科学院 马立克氏病病毒快速检测试纸条
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3079718B1 (en) * 2013-12-11 2025-04-09 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Human herpesvirus trimeric glycoprotein b, protein complexes comprising trimeric gb and their use as vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
WO1990002803A2 (en) * 1988-09-13 1990-03-22 Rhone-Merieux S.A. Viral vaccines
US5558860A (en) * 1988-09-13 1996-09-24 Rhone Merieux Viral vaccines
JP3428666B2 (ja) * 1991-07-09 2003-07-22 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
US5659153A (en) * 1995-03-03 1997-08-19 International Business Machines Corporation Thermoformed three dimensional wiring module

Also Published As

Publication number Publication date
WO1996038565A1 (fr) 1996-12-05
JP3933689B2 (ja) 2007-06-20
ATE236254T1 (de) 2003-04-15
DE69627109D1 (de) 2003-05-08
EP0774513B1 (en) 2003-04-02
AU5780796A (en) 1996-12-18
US6013261A (en) 2000-01-11
CA2196416C (en) 2011-03-08
EP0774513A1 (en) 1997-05-21
JPH08322559A (ja) 1996-12-10
CN1155710C (zh) 2004-06-30
MX9700870A (es) 1997-09-30
EP0774513A4 (en) 1999-10-13
BR9606412A (pt) 1997-09-30
CA2196416A1 (en) 1996-12-05
AU692395B2 (en) 1998-06-04
DE69627109T2 (de) 2003-12-18
CN1159209A (zh) 1997-09-10

Similar Documents

Publication Publication Date Title
AU1628895A (en) Recombinant virus
AU543168B2 (en) Stabilizing and selecting recombinant dna host cells
EP0502956A4 (en) Production of recombinant human interleukin-1 inhibitor
AU625328B2 (en) Recombinant varicella-zoster glycoproteins and their derivatives
AU1632392A (en) Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus
EP0175787A4 (en) RECOMBINANT gB-gD VACCINE AGAINST HERPES SIMPLEX.
PT1021553E (pt) Cassette de expressao eucariotica de genes e suas utilizacoes
ES2196148T3 (es) (hipersvirus) recombinado y utilizacion de un promotor de gen gb.
DK0566554T3 (da) Fremstilling af rekombinante proteiner ved anvendelse af herpesviruspromotorer og VP16-transaktivatorer
AU4446593A (en) Recombinant adenovirus vaccines
LU91303I2 (fr) Gallivac HVT IBD- virus vivant recombinant vHVT013-69,au minimum 3,0 log 10 UFP
AU2133292A (en) Hcmv-specific peptides, agents therefor and the use thereof
DK0553667T3 (da) Opløselig LDL-receptor, dens fremstilling og anvendelse
AU6889194A (en) Recombinant adenovirus vaccines
AU4666189A (en) Cloning and expression of a protein which modulates cellular response to type i interferon
PT576092E (pt) Vacina de virus de herpes felino recombinante
DE69332480D1 (de) Impfstoff-vektoren von rekombinantem katzen-herpesvirus
DE68929544D1 (de) Virale Vakzine
EP0623172A4 (en) RECOMBINANT POXVIRUS AS A VACCINE AGAINST THE VIRUS OF MAREK DISEASE.
KR950702244A (ko) 백신으로서의 즉석 초기 hsv-2 비루스 단백질 icp27(immediatie early hsv-2 viral protein icp27 as vaccine)
AU2521888A (en) Recombinant dna constructs containing an r3 promoter